BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
161 – 170 of 3085
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Re : Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol 2019;75:423–32
- Contribution to journal › Letter
-
Mark
How good are pathogenicity predictors in detecting benign variants?
- Contribution to journal › Article
-
Mark
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
- Contribution to journal › Article
-
Mark
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
- Contribution to journal › Article
-
Mark
The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma
- Contribution to journal › Article
-
Mark
Prostate cancer risk-associated single-nucleotide polymorphism affects prostate-specific antigen glycosylation and its function
- Contribution to journal › Article
-
Mark
Circulating high sensitivity C reactive protein concentrations and risk of lung cancer : Nested case-control study within Lung Cancer Cohort Consortium
- Contribution to journal › Article
-
Mark
Multidimensional intratumour heterogeneity in neuroblastoma
- Contribution to journal › Debate/Note/Editorial
-
Mark
Perspective on prostate cancer screening
- Contribution to journal › Scientific review
-
Mark
Tuning the protein phosphorylation by receptor type protein tyrosine phosphatase epsilon (PTPRE) in normal and cancer cells
- Contribution to journal › Article
